Chemical transformation of xenobiotics by the human gut microbiota

Science

Volumn 356, Issue 6344, 2017, Pages 1246-1257

  Koppel, Nitzan ^a   Rekdal, Vayu Maini ^a   Balskus, Emily P ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CHEMICAL COMPOUND; CHOLINE; DIGOXIN; FUNCTIONAL GROUP; GASTROINTESTINAL AGENT; HEAVY METAL; HERBACEOUS AGENT; HETEROCYCLIC AMINE; INDUSTRIAL CHEMICAL; IRINOTECAN; LYASE; MICROBIAL ENZYME; NUTRITION SUPPLEMENT; PLANT MEDICINAL PRODUCT; SWEETENING AGENT; XENOBIOTIC AGENT; DRUG;

BIOTRANSFORMATION; DIGESTIVE SYSTEM; DRUG; DRUG DEVELOPMENT; ENZYME; ENZYME ACTIVITY; GENE; GENE EXPRESSION; MEDICINE; METABOLISM; MICROBIAL ACTIVITY; MICROORGANISM; RISK ASSESSMENT; TOXICITY; TOXICOLOGY; XENOBIOTICS;

AGE; BACTERIUM TRANSFORMATION; BIOCHEMISTRY; BIOTRANSFORMATION; CANCER CHEMOTHERAPY; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG METABOLISM; ENZYME MECHANISM; FAT INTAKE; GENETIC ANALYSIS; HERBAL MEDICINE; HOST; HUMAN; HYDROLYSIS; INTESTINE FLORA; MANUFACTURING INDUSTRY; MICROBIAL ACTIVITY; MICROBIAL GENE; MICROBIAL METABOLISM; NUTRIENT CONTENT; ORGANISMAL INTERACTION; PERSONALIZED MEDICINE; POLLUTANT; PRIORITY JOURNAL; PROTEIN INTAKE; RADICAL REACTION; REACTION ANALYSIS; REVIEW; RISK ASSESSMENT; TRADITIONAL MEDICINE; XENOBIOTIC METABOLISM; BACTERIUM; CHEMISTRY; ENZYMOLOGY; FOOD; GENETICS; METABOLISM; PHYSIOLOGY; RESEARCH; TRENDS;

BACTERIA; ENVIRONMENTAL POLLUTANTS; FOOD; GASTROINTESTINAL MICROBIOME; HUMANS; PHARMACEUTICAL PREPARATIONS; RESEARCH; XENOBIOTICS;

EID: 85021282971     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aag2770     Document Type: Review

References (127)

1. A. H. Moeller et al., Cospeciation of gut microbiota with hominids. Science 353, 380-382 (2016). doi: 10.1126/ science.aaf3951; PMID: 27463672
2. C. G. Buffie et al., Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517, 205-208 (2015). doi: 10.1038/nature13828; PMID: 25337874
3. G. Sharon et al., Specialized metabolites from the microbiome in health and disease. Cell Metab. 20, 719-730 (2014). doi: 10.1016/j.cmet.2014.10.016; PMID: 25440054
4. A. Koh, F. De Vadder, P. Kovatcheva-Datchary, F. Bäckhed, From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 165, 1332-1345 (2016). doi: 10.1016/j.cell.2016.05.041; PMID: 27259147
5. T. Sousa et al., The gastrointestinal microbiota as a site for the biotransformation of drugs. Int. J. Pharm. 363, 1-25 (2008). doi: 10.1016/j.ijpharm.2008.07.009; PMID: 18682282
6. H. Danielsson, B. Gustafsson, On serum-cholesterol levels and neutral fecal sterols in germ-free rats; bile acids and steroids 59. Arch. Biochem. Biophys. 83, 482-485 (1959). doi: 10.1016/0003-9861(59)90056-6; PMID: 13813997
7. R. Sender, S. Fuchs, R. Milo, Revised estimates for the number of human and bacteria cells in the body. PLOS Biol. 14, e1002533 (2016). doi: 10.1371/journal.pbio.1002533; PMID: 27541692
8. J. Aron-Wisnewsky, J. Doré, K. Clement, The importance of the gut microbiota after bariatric surgery. Nat. Rev. Gastroenterol. Hepatol. 9, 590-598 (2012). doi: 10.1038/ nrgastro.2012.161; PMID: 22926153
9. P. B. Eckburg et al., Diversity of the human intestinal microbial flora. Science 308, 1635-1638 (2005). doi: 10.1126/science.1110591; PMID: 15831718
10. The Human Microbiome Project Consortium, Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214 (2012). doi: 10.1038/nature11234; PMID: 22699609
11. B. Wang, L. Hu, T. Siahaan, Drug Delivery: Principles and Applications (Wiley, ed. 2, 2016).
12. R. J. Linhardt, P. M. Galliher, C. L. Cooney, Polysaccharide lyases. Appl. Biochem. Biotechnol. 12, 135-176 (1987). doi: 10.1007/BF02798420; PMID: 3521491
13. A. Ryan et al., Identification of NAD(P)H quinone oxidoreductase activity in azoreductases from P. aeruginosa: Azoreductases and NAD(P)H quinone oxidoreductases belong to the same FMN-dependent superfamily of enzymes. PLOS ONE 9, e98551 (2014). doi: 10.1371/journal. pone.0098551; PMID: 24915188
14. A. Martínez-del Campo et al., Characterization and detection of a widely distributed gene cluster that predicts anaerobic choline utilization by human gut bacteria. mBio 6, e00042-15 (2015). doi: 10.1128/mBio.00042-15; PMID: 25873372
15. A. El Kaoutari, F. Armougom, J. I. Gordon, D. Raoult, B. Henrissat, The abundance and variety of carbohydrateactive enzymes in the human gut microbiota. Nat. Rev. Microbiol. 11, 497-504 (2013). doi: 10.1038/nrmicro3050; PMID: 23748339
16. B. J. Levin et al., A prominent glycyl radical enzyme in human gut microbiomes metabolizes trans-4-hydroxy-L-proline. Science 355, eaai8386 (2017). doi: 10.1126/science.aai8386; PMID: 28183913
17. K. Kurokawa et al., Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 14, 169-181 (2007). doi: 10.1093/dnares/dsm018; PMID: 17916580
18. K. Ellrott, L. Jaroszewski, W. Li, J. C. Wooley, A. Godzik, Expansion of the protein repertoire in newly explored environments: Human gut microbiome specific protein families. PLOS Comput. Biol. 6, e1000798 (2010). doi: 10.1371/journal.pcbi.1000798; PMID: 20532204
19. P. Jancova, P. Anzenbacher, E. Anzenbacherova, Phase II drug metabolizing enzymes. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 154, 103-116 (2010). doi: 10.5507/bp.2010.017; PMID: 20668491
20. J. Wang, V. Yadav, A. L. Smart, S. Tajiri, A. W. Basit, Stability of peptide drugs in the colon. Eur. J. Pharm. Sci. 78, 31-36 (2015). doi: 10.1016/j.ejps.2015.06.018; PMID: 26111980
21. H. Tozaki et al., Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents: Implications in peptide delivery to the colon. J. Pharm. Pharmacol. 49, 164-168 (1997). doi: 10.1111/ j.2042-7158.1997.tb06773.x; PMID: 9055189
22. W. W. Kallemeijn, M. D. Witte, T. Wennekes, J. M. Aerts, Mechanism-based inhibitors of glycosidases: Design and applications. Adv. Carbohydr. Chem. Biochem. 71, 297-338 (2014). doi: 10.1016/B978-0-12-800128-8.00004-2; PMID: 25480507
23. B. D. Wallace et al., Structure and inhibition of microbiome b-glucuronidases essential to the alleviation of cancer drug toxicity. Chem. Biol. 22, 1238-1249 (2015). doi: 10.1016/ j.chembiol.2015.08.005; PMID: 26364932
24. J. E. Ulmer et al., Characterization of glycosaminoglycan (GAG) sulfatases from the human gut symbiont Bacteroides thetaiotaomicron reveals the first GAG-specific bacterial endosulfatase. J. Biol. Chem. 289, 24289-24303 (2014). doi: 10.1074/jbc.M114.573303; PMID: 25002587
25. G. Lukatela et al., Crystal structure of human arylsulfatase A: The aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis. Biochemistry 37, 3654-3664 (1998). doi: 10.1021/bi9714924; PMID: 9521684
26. B. D. Wallace et al., Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831-835 (2010). doi: 10.1126/science.1191175; PMID: 21051639
27. K. S. Saitta et al., Bacterial b-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: Mode of action and pharmacokinetics. Xenobiotica 44, 28-35 (2014). doi: 10.3109/00498254.2013.811314; PMID: 23829165
28. J. H. Carter, M. A. McLafferty, P. Goldman, Role of the gastrointestinal microflora in amygdalin (laetrile)-induced cyanide toxicity. Biochem. Pharmacol. 29, 301-304 (1980). doi: 10.1016/0006-2952(80)90504-3; PMID: 7362642
29. T. Nimura, T. Tokieda, T. Yamaha, Partial purification and some properties of cyclamate sulfamatase. J. Biochem. 75, 407-417 (1974). doi: 10.1093/oxfordjournals.jbchem. a130407; PMID: 4209783
30. D. R. Donohoe et al., The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 13, 517-526 (2011). doi: 10.1016/ j.cmet.2011.02.018; PMID: 21531334
31. A. J. Cooper et al., Cysteine S-conjugate b-lyases: Important roles in the metabolism of naturally occurring sulfur and selenium-containing compounds, xenobiotics and anticancer agents. Amino Acids 41, 7-27 (2011). doi: 10.1007/s00726- 010-0552-0; PMID: 20306345
32. S. P. Claus, H. Guillou, S. Ellero-Simatos, The gut microbiota: A major player in the toxicity of environmental pollutants? NPJ Biofilms Microbiomes 2, 16003 (2016). doi: 10.1038/ npjbiofilms.2016.3
33. I. Rossol, A. Pühler, The Corynebacterium glutamicum aecD gene encodes a C-S lyase with a,b-elimination activity that degrades aminoethylcysteine. J. Bacteriol. 174, 2968-2977 (1992). doi: 10.1128/jb.174.9.2968-2977.1992; PMID: 1569026
34. F. Rafii, J. D. Hall, C. E. Cerniglia, Mutagenicity of azo dyes used in foods, drugs and cosmetics before and after reduction by Clostridium species from the human intestinal tract. Food Chem. Toxicol. 35, 897-901 (1997). doi: 10.1016/ S0278-6915(97)00060-4; PMID: 9409630
35. S. C. Lee, A. G. Renwick, Sulphoxide reduction by rat intestinal flora and by Escherichia coli in vitro. Biochem. Pharmacol. 49, 1567-1576 (1995). doi: 10.1016/0006-2952 (95)00093-F; PMID: 7786297
36. H. Laue, M. Friedrich, J. Ruff, A. M. Cook, Dissimilatory sulfite reductase (desulfoviridin) of the taurine-degrading, nonsulfate- reducing bacterium Bilophila wadsworthia RZATAU contains a fused DsrB-DsrD subunit. J. Bacteriol. 183, 1727-1733 (2001). doi: 10.1128/JB.183.5.1727-1733.2001; PMID: 11160104
37. H. J. Haiser et al., Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 341, 295-298 (2013). doi: 10.1126/science.1235872; PMID: 23869020
38. M. A. Peppercorn, P. Goldman, The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J. Pharmacol. Exp. Ther. 181, 555-562 (1972). PMID: 4402374
39. K. Lavrijsen et al., Reduction of the prodrug loperamide oxide to its active drug loperamide in the gut of rats, dogs, and humans. Drug Metab. Dispos. 23, 354-362 (1995). PMID: 7628301
40. F. Rafii, C. E. Cerniglia, Reduction of azo dyes and nitroaromatic compounds by bacterial enzymes from the human intestinal tract. Environ. Health Perspect. 103 (suppl. 5), 17-19 (1995). doi: 10.1289/ehp.95103s417; PMID: 8565901
41. T. Kumano, E. Fujiki, Y. Hashimoto, M. Kobayashi, Discovery of a sesamin-metabolizing microorganism and a new enzyme. Proc. Natl. Acad. Sci. U.S.A. 113, 9087-9092 (2016). doi: 10.1073/pnas.1605050113; PMID: 27444012
42. T. Ticak, D. J. Kountz, K. E. Girosky, J. A. Krzycki, D. J. Ferguson Jr., A nonpyrrolysine member of the widely distributed trimethylamine methyltransferase family is a glycine betaine methyltransferase. Proc. Natl. Acad. Sci. U.S.A. 111, E4668-E4676 (2014). doi: 10.1073/pnas.1409642111; PMID: 25313086
43. C. Deloménie et al., Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: Evidence for highly selective acetylation of 5- aminosalicylic acid. J. Bacteriol. 183, 3417-3427 (2001). doi: 10.1128/JB.183.11.3417-3427.2001; PMID: 11344150
44. D. Sutton, A. M. Butler, L. Nadin, M. Murray, Role of CYP3A4 in human hepatic diltiazem N-demethylation: Inhibition of CYP3A4 activity by oxidized diltiazem metabolites. J. Pharmacol. Exp. Ther. 282, 294-300 (1997). PMID: 9223567
45. W. Buckel, B. T. Golding, Radical enzymes in anaerobes. Annu. Rev. Microbiol. 60, 27-49 (2006). doi: 10.1146/ annurev.micro.60.080805.142216; PMID: 16704345
46. S. Bodea, M. A. Funk, E. P. Balskus, C. L. Drennan, Molecular basis of C-N bond cleavage by the glycyl radical enzyme choline trimethylamine-lyase. Cell Chem. Biol. 23, 1206-1216 (2016). doi: 10.1016/j.chembiol.2016.07.020; PMID: 27642068
47. T. Selmer, P. I. Andrei, p-Hydroxyphenylacetate decarboxylase from Clostridium difficile. Eur. J. Biochem. 268, 1363-1372 (2001). doi: 10.1046/j.1432-1327.2001.02001.x; PMID: 11231288
48. T. A. Clayton, D. Baker, J. C. Lindon, J. R. Everett, J. K. Nicholson, Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc. Natl. Acad. Sci. U.S.A. 106, 14728-14733 (2009). doi: 10.1073/pnas.0904489106; PMID: 19667173
49. X. He, M. L. Marco, C. M. Slupsky, Emerging aspects of food and nutrition on gut microbiota. J. Agric. Food Chem. 61, 9559-9574 (2013). doi: 10.1021/jf4029046; PMID: 24028159
50. H. J. Flint, E. A. Bayer, M. T. Rincon, R. Lamed, B. A. White, Polysaccharide utilization by gut bacteria: Potential for new insights from genomic analysis. Nat. Rev. Microbiol. 6, 121-131 (2008). doi: 10.1038/nrmicro1817; PMID: 18180751
51. N. M. Koropatkin, E. A. Cameron, E. C. Martens, How glycan metabolism shapes the human gut microbiota. Nat. Rev. Microbiol. 10, 323-335 (2012). doi: 10.1038/nrmicro2746; PMID: 22491358
52. A. Caminero et al., Differences in gluten metabolism among healthy volunteers, coeliac disease patients and first-degree relatives. Br. J. Nutr. 114, 1157-1167 (2015). doi: 10.1017/ S0007114515002767; PMID: 26428276
53. A. Caminero et al., Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity. Gastroenterology 151, 670-683 (2016). doi: 10.1053/j.gastro.2016.06.041; PMID: 27373514
54. F. Blachier, F. Mariotti, J. F. Huneau, D. Tomé, Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids 33, 547-562 (2007). doi: 10.1007/s00726-006- 0477-9; PMID: 17146590
55. W. R. Wikoff et al., Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. U.S.A. 106, 3698-3703 (2009). doi: 10.1073/pnas.0812874106; PMID: 19234110
56. B. B. Williams et al., Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe 16, 495-503 (2014). doi: 10.1016/j.chom.2014.09.001; PMID: 25263219
57. A. S. Devlin et al., Modulation of a circulating uremic Solute via rational genetic manipulation of the gut microbiota. Cell Host Microbe 20, 709-715 (2016). doi: 10.1016/ j.chom.2016.10.021; PMID: 27916477
58. C. E. Cho, M. A. Caudill, Trimethylamine-N-oxide: Friend, foe, or simply caught in the cross-fire? Trends Endocrinol. Metab. 28, 121-130 (2017). doi: 10.1016/j.tem.2016.10.005; PMID: 27825547
59. D. Fennema, I. R. Phillips, E. A. Shephard, Trimethylamine and trimethylamine N-oxide, a flavin-containing monooxygenase 3 (FMO3)-mediated host-microbiome metabolic axis implicated in health and disease. Drug Metab. Dispos. 44, 1839-1850 (2016). doi: 10.1124/dmd.116.070615; PMID: 27190056
60. J. C. Escolà-Gil et al., The cholesterol content of Western diets plays a major role in the paradoxical increase in highdensity lipoprotein cholesterol and upregulates the macrophage reverse cholesterol transport pathway. Arterioscler. Thromb. Vasc. Biol. 31, 2493-2499 (2011). doi: 10.1161/ATVBAHA.111.236075; PMID: 21885848
61. I. A. Macdonald, V. D. Bokkenheuser, J. Winter, A. M. McLernon, E. H. Mosbach, Degradation of steroids in the human gut. J. Lipid Res. 24, 675-700 (1983). PMID: 6350517
62. P. Gérard et al., Gnotobiotic rats harboring human intestinal microbiota as a model for studying cholesterol-tocoprostanol conversion. FEMS Microbiol. Ecol. 47, 337-343 (2004). doi: 10.1016/S0168-6496(03)00285-X; PMID: 19712322
63. D. Ren, L. Li, A. W. Schwabacher, J. W. Young, D. C. Beitz, Mechanism of cholesterol reduction to coprostanol by Eubacterium coprostanoligenes ATCC 51222. Steroids 61, 33-40 (1996). doi: 10.1016/0039-128X(95)00173-N; PMID: 8789734
64. C. A. Dujovne et al., Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am. J. Cardiol. 90, 1092-1097 (2002). doi: 10.1016/S0002-9149(02)02798-4; PMID: 12423709
65. L. Valdés et al., The relationship between phenolic compounds from diet and microbiota: Impact on human health. Food Funct. 6, 2424-2439 (2015). doi: 10.1039/ C5FO00322A; PMID: 26068710
66. R. García-Villalba, D. Beltrán, J. C. Espín, M. V. Selma, F. A. Tomás-Barberán, Time course production of urolithins from ellagic acid by human gut microbiota. J. Agric. Food Chem. 61, 8797-8806 (2013). doi: 10.1021/jf402498b; PMID: 23984796
67. C. Atkinson, C. L. Frankenfeld, J. W. Lampe, Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health. Exp. Biol. Med. 230, 155-170 (2005). PMID: 15734719
68. J. Tang et al., Tea consumption and mortality of all cancers, CVD and all causes: A meta-analysis of eighteen prospective cohort studies. Br. J. Nutr. 114, 673-683 (2015). doi: 10.1017/ S0007114515002329; PMID: 26202661
69. T. Clavel, G. Henderson, W. Engst, J. Doré, M. Blaut, Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. FEMS Microbiol. Ecol. 55, 471-478 (2006). doi: 10.1111/ j.1574-6941.2005.00057.x; PMID: 16466386
70. B. A. Bopp, R. C. Sonders, J. W. Kesterson, A. G. Renwick, Toxicological aspects of cyclamate and cyclohexylamine. Crit. Rev. Toxicol. 16, 213-306 (1986). doi: 10.3109/ 10408448609037465; PMID: 2420530
71. A. G. Renwick, S. M. Tarka, Microbial hydrolysis of steviol glycosides. Food Chem. Toxicol. 46 (suppl. 7), S70-S74 (2008). doi: 10.1016/j.fct.2008.05.008; PMID: 18550247
72. R. Krishnan et al., The effect of dietary xylitol on the ability of rat caecal flora to metabolise xylitol. Aust. J. Exp. Biol. Med. Sci. 58, 639-652 (1980). doi: 10.1038/icb.1980.66; PMID: 6791623
73. A. G. Renwick, The metabolism of intense sweeteners. Xenobiotica 16, 1057-1071 (1986). doi: 10.3109/ 00498258609038983; PMID: 3541395
74. F. Kassie et al., Intestinal microflora plays a crucial role in the genotoxicity of the cooked food mutagen 2-amino-3- methylimidazo [4,5-f]quinoline. Carcinogenesis 22, 1721-1725 (2001). doi: 10.1093/carcin/22.10.1721; PMID: 11577015
75. C. Humblot et al., b-glucuronidase in human intestinal microbiota is necessary for the colonic genotoxicity of the food-borne carcinogen 2-amino-3-methylimidazo[4,5-f] quinoline in rats. Carcinogenesis 28, 2419-2425 (2007). doi: 10.1093/carcin/bgm170; PMID: 17660508
76. A. J. Cross et al., A large prospective study of meat consumption and colorectal cancer risk: An investigation of potential mechanisms underlying this association. Cancer Res. 70, 2406-2414 (2010). doi: 10.1158/0008-5472.CAN- 09-3929; PMID: 20215514
77. F. Rafii, W. Franklin, C. E. Cerniglia, Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora. Appl. Environ. Microbiol. 56, 2146-2151 (1990). PMID: 2202258
78. J. F. Borzelleca, K. Depukat, J. B. Hallagan, Lifetime toxicity/carcinogenicity studies of FD & C blue no. 1 (brilliant blue FCF) in rats and mice. Food Chem. Toxicol. 28, 221-234 (1990). doi: 10.1016/0278-6915(90)90034-K; PMID: 2358248
79. Z. Singh, P. Chadha, Textile industry and occupational cancer. J. Occup. Med. Toxicol. 11, 39 (2016). doi: 10.1186/s12995- 016-0128-3; PMID: 27532013
80. R. P. Bos et al., Internal exposure of rats to benzidine derived from orally administered benzidine-based dyes after intestinal azo reduction. Toxicology 40, 207-213 (1986). doi: 10.1016/0300-483X(86)90080-6; PMID: 3726894
81. J. R. Ingelfinger, Melamine and the global implications of food contamination. N. Engl. J. Med. 359, 2745-2748 (2008). doi: 10.1056/NEJMp0808410; PMID: 19109571
82. X. Zheng et al., Melamine-induced renal toxicity is mediated by the gut microbiota. Sci. Transl. Med. 5, 172ra22 (2013). doi: 10.1126/scitranslmed.3005114; PMID: 23408055
83. H. Wang, C. Geng, J. Li, A. Hu, C. P. Yu, Characterization of a novel melamine-degrading bacterium isolated from a melamine-manufacturing factory in China. Appl. Microbiol. Biotechnol. 98, 3287-3293 (2014). doi: 10.1007/s00253- 013-5363-2; PMID: 24297478
84. I. R. Rowland, M. J. Davies, P. Grasso, Metabolism of methylmercuric chloride by the gastro-intestinal flora of the rat. Xenobiotica 8, 37-43 (1978). doi: 10.3109/ 00498257809060381; PMID: 626001
85. I. R. Rowland, M. J. Davies, J. G. Evans, The effect of the gastrointestinal flora on tissue content of mercury and organomercurial neurotoxicity in rats given methylmercuric chloride. Dev. Toxicol. Environ. Sci. 8, 79-82 (1980). PMID: 7308081
86. C. A. Liebert, J. Wireman, T. Smith, A. O. Summers, Phylogeny of mercury resistance (mer) operons of gramnegative bacteria isolated from the fecal flora of primates. Appl. Environ. Microbiol. 63, 1066-1076 (1997). PMID: 9055422
87. S. E. Rothenberg et al., The role of gut microbiota in fetal methylmercury exposure: Insights from a pilot study. Toxicol. Lett. 242, 60-67 (2016). doi: 10.1016/j.toxlet.2015.11.022; PMID: 26626101
88. R. A. Diaz-Bone, T. R. van de Wiele, Biovolatilization of metal(loid)s by intestinal microorganisms in the simulator of the human intestinal microbial ecosystem. Environ. Sci. Technol. 43, 5249-5256 (2009). doi: 10.1021/es900544c; PMID: 19708349
89. P. Spanogiannopoulos, E. N. Bess, R. N. Carmody, P. J. Turnbaugh, The microbial pharmacists within us: A metagenomic view of xenobiotic metabolism. Nat. Rev. Microbiol. 14, 273-287 (2016). doi: 10.1038/nrmicro.2016.17; PMID: 26972811
90. S. Takeno, Y. Hirano, A. Kitamura, T. Sakai, Comparative developmental toxicity and metabolism of nitrazepam in rats and mice. Toxicol. Appl. Pharmacol. 121, 233-238 (1993). doi: 10.1006/taap.1993.1150; PMID: 8346540
91. H. Okuda et al., Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs. Drug Metab. Dispos. 25, 270-273 (1997). PMID: 9152608
92. M. Vétizou et al., Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079-1084 (2015). doi: 10.1126/science.aad1329; PMID: 26541610
93. N. R. Shin et al., An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727-735 (2014). doi: 10.1136/gutjnl-2012-303839; PMID: 23804561
94. R. A. van Hogezand et al., Bacterial acetylation of 5- aminosalicylic acid in faecal suspensions cultured under aerobic and anaerobic conditions. Eur. J. Clin. Pharmacol. 43, 189-192 (1992). doi: 10.1007/BF01740669; PMID: 1425876
95. H. A. Strong, A. G. Renwick, C. F. George, Y. F. Liu, M. J. Hill, The reduction of sulphinpyrazone and sulindac by intestinal bacteria. Xenobiotica 17, 685-696 (1987). doi: 10.3109/ 00498258709043976; PMID: 3630204
96. P. Lehouritis et al., Local bacteria affect the efficacy of chemotherapeutic drugs. Sci. Rep. 5, 14554 (2015). doi: 10.1038/srep14554; PMID: 26416623
97. D. B. Calne et al., Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa. BMJ 3, 729-732 (1971). doi: 10.1136/ bmj.3.5777.729; PMID: 4938431
98. J. Bergmark et al., Decarboxylation of orally administered L-dopa in the human digestive tract. Naunyn Schmiedebergs Arch. Pharmacol. 272, 437-440 (1972). doi: 10.1007/ BF00501249; PMID: 4260263
99. B. R. Goldin, M. A. Peppercorn, P. Goldman, Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat. J. Pharmacol. Exp. Ther. 186, 160-166 (1973). PMID: 4723308
100. J. G. Nutt, N. H. Holford, The response to levodopa in Parkinson's disease: Imposing pharmacological law and order. Ann. Neurol. 39, 561-573 (1996). doi: 10.1002/ ana.410390504; PMID: 8619540
101. K. Zhang, Y. Ni, Tyrosine decarboxylase from Lactobacillus brevis: Soluble expression and characterization. Protein Expr. Purif. 94, 33-39 (2014). doi: 10.1016/j.pep.2013.10.018; PMID: 24211777
102. G. Sharon, T. R. Sampson, D. H. Geschwind, S. K. Mazmanian, The central nervous system and the gut microbiome. Cell 167, 915-932 (2016). doi: 10.1016/j.cell.2016.10.027; PMID: 27814521
103. A. S. Relman, Closing the books on laetrile. N. Engl. J. Med. 306, 236 (1982). doi: 10.1056/NEJM198201283060410; PMID: 7054687
104. C. G. Moertel et al., A clinical trial of amygdalin (laetrile) in the treatment of human cancer. N. Engl. J. Med. 306, 201-206 (1982). doi: 10.1056/NEJM198201283060403; PMID: 7033783
105. G. J. Strugala, A. G. Rauws, R. Elbers, Intestinal first pass metabolism of amygdalin in the rat in vitro. Biochem. Pharmacol. 35, 2123-2128 (1986). doi: 10.1016/0006- 2952(86)90580-0; PMID: 3089225
106. R. Feng et al., Transforming berberine into its intestineabsorbable form by the gut microbiota. Sci. Rep. 5, 12155 (2015). doi: 10.1038/srep12155; PMID: 26174047
107. Y. Liu et al., Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes. Toxicol. Sci. 91, 356-364 (2006). doi: 10.1093/toxsci/kfj164; PMID: 16547074
108. K. T. Konstantinidis, J. M. Tiedje, Genomic insights that advance the species definition for prokaryotes. Proc. Natl. Acad. Sci. U.S.A. 102, 2567-2572 (2005). doi: 10.1073/ pnas.0409727102; PMID: 15701695
109. J. Li et al., An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834-841 (2014). doi: 10.1038/nbt.2942; PMID: 24997786
110. A. Das, M. Srinivasan, T. S. Ghosh, S. S. Mande, Xenobiotic metabolism and gut microbiomes. PLOS ONE 11, e0163099 (2016). doi: 10.1371/journal.pone.0163099; PMID: 27695034
111. W. Withering, An Account of the Foxglove (printed by M. Swinney for G. G. J. and J. Robinson, London, Birmingham, 1785).
112. J. Lindenbaum, D. G. Rund, V. P. Butler Jr., D. Tse-Eng, J. R. Saha, Inactivation of digoxin by the gut flora: Reversal by antibiotic therapy. N. Engl. J. Med. 305, 789-794 (1981). doi: 10.1056/NEJM198110013051403; PMID: 7266632
113. J. R. Saha, V. P. Butler Jr., H. C. Neu, J. Lindenbaum, Digoxin-inactivating bacteria: Identification in human gut flora. Science 220, 325-327 (1983). doi: 10.1126/ science.6836275; PMID: 6836275
114. S. Craciun, E. P. Balskus, Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc. Natl. Acad. Sci. U.S.A. 109, 21307-21312 (2012). doi: 10.1073/ pnas.1215689109; PMID: 23151509
115. S. Craciun, J. A. Marks, E. P. Balskus, Characterization of choline trimethylamine-lyase expands the chemistry of glycyl radical enzymes. ACS Chem. Biol. 9, 1408-1413 (2014). doi: 10.1021/cb500113p; PMID: 24854437
116. K. A. Romano, E. I. Vivas, D. Amador-Noguez, F. E. Rey, Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. mBio 6, e02481-14 (2015). doi: 10.1128/mBio.02481-14; PMID: 25784704
117. Z. Wang et al., Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163, 1585-1595 (2015). doi: 10.1016/ j.cell.2015.11.055; PMID: 26687352
118. The Human Microbiome Jumpstart Reference Strains Consortium, A catalog of reference genomes from the human microbiome. Science 328, 994-999 (2010). doi: 10.1126/ science.1183605; PMID: 20489017
119. D. Berry et al., Host-compound foraging by intestinal microbiota revealed by single-cell stable isotope probing. Proc. Natl. Acad. Sci. U.S.A. 110, 4720-4725 (2013). doi: 10.1073/pnas.1219247110; PMID: 23487774
120. R. S. Lasken, Genomic sequencing of uncultured microorganisms from single cells. Nat. Rev. Microbiol. 10, 631-640 (2012). doi: 10.1038/nrmicro2857; PMID: 22890147
121. L. Tasse et al., Functional metagenomics to mine the human gut microbiome for dietary fiber catabolic enzymes. Genome Res. 20, 1605-1612 (2010). doi: 10.1101/gr.108332.110; PMID: 20841432
122. M. Li et al., Symbiotic gut microbes modulate human metabolic phenotypes. Proc. Natl. Acad. Sci. U.S.A. 105, 2117-2122 (2008). doi: 10.1073/pnas.0712038105; PMID: 18252821
123. J. A. Gerlt et al., Enzyme Function Initiative-Enzyme Similarity Tool (EFI-EST): A web tool for generating protein sequence similarity networks. Biochim. Biophys. Acta 1854, 1019-1037 (2015). doi: 10.1016/j.bbapap.2015.04.015; PMID: 25900361
124. C. A. Kolmeder et al., Comparative metaproteomics and diversity analysis of human intestinal microbiota testifies for its temporal stability and expression of core functions. PLOS ONE 7, e29913 (2012). doi: 10.1371/journal. pone.0029913; PMID: 22279554
125. D. Zeevi et al., Personalized nutrition by prediction of glycemic responses. Cell 163, 1079-1094 (2015). doi: 10.1016/j.cell.2015.11.001; PMID: 26590418
126. K. S. Kim et al., Associations of organochlorine pesticides and polychlorinated biphenyls in visceral vs. subcutaneous adipose tissue with type 2 diabetes and insulin resistance. Chemosphere 94, 151-157 (2014). doi: 10.1016/j.chemosphere.2013.09.066; PMID: 24161582
127. C. S. Karigar, S. S. Rao, Role of microbial enzymes in the bioremediation of pollutants: A review. Enzyme Res. 2011, 805187 (2011). doi: 10.4061/2011/805187; PMID: 21912739 such material.